Requires Adobe Acrobat Reader

Table 13.8

Adjusted Graft Survival, Heart-Lung Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

		3 Months			1 Year			5 Years			10 Years
		(Tx 2005 - 2006)			(Tx 2005 - 2006)			(Tx 2001 - 2006)			(Tx 1996 - 2006)
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	65	80.5%	4.9%	65	74.2%	5.4%	190	45.6%	4.9%	433	25.6%	3.3%
Primary Diagnosis	Congenital Disease	14	53.7%	13.6%	14	53.7%	13.6%	54	45.0%	7.2%	160	22.8%	4.6%
	Primary Pulmonary Hypertension	19	85.5%	7.9%	19	85.5%	7.9%	55	60.1%	8.8%	99	36.0%	7.6%
	Cystic Fibrosis	2	+	+	2	+	+	5	0.0%	0.0%	12	34.5%	14.5%
	Emphysema/COPD	1	100.0%	0.0%	1	0.0%	0.0%	2	0.0%	0.0%	14	30.5%	12.2%
	Other	9	89.1%	10.0%	9	78.1%	13.8%	23	45.8%	12.1%	40	22.2%	9.1%
	Unknown	20	85.5%	7.5%	20	75.5%	9.5%	51	41.2%	9.3%	108	18.3%	7.2%

Source: OPTN/SRTR Data as of May 1, 2008.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.

Requires Adobe Acrobat Reader